EGFR and non-small cell lung carcinoma: Recently, Ochiai S, et al. suggested that EGFR mutational status may also influence the recurrence pattern after definitive chemo-radiotherapy in locally-advanced NSCLC, with a higher prevalence of distant recurrences among EGFR mutated tumors, compared with EGFR wild type, which instead experience higher loco-regional failures [14].